Trial Registration
tumor
TUMOR, METASTATIC BREAST CANCER
ClinicalTrials.gov Identifier: This randomized clinical trial examines the effect of adding fulvestrant to alisertib on objective tumor response rates in endocrine-resistant metastatic breast cancer.